single blind


Also found in: Dictionary, Wikipedia.
Related to single blind: Double Blinded, double blinded study, Triple blind, single blind study

single blind

 
pertaining to a clinical trial or other experiment in which no subject knows whether he or she is receiving particular treatments or even lack of treatment (see placebo), but the administrator does have that information.

single blind

/sin·gle blind/ (sing´g'l blīnd) pertaining to an experiment in which subjects do not know which treatment they are receiving.

single blind

n.
A testing procedure in which the administrators do not tell the subjects if they are being given a test treatment or a control treatment in order to avoid bias in the results.

sin′gle-blind′ adj.
References in periodicals archive ?
The final moment of the card game, a brilliant example of architectural closure, portrays two desperate men staking their entire lives "on the single blind turn of a card.
OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced today that it has completed enrollment of 40 patients in the second of three dose cohorts in Lm-LLO-E7-07, a randomized, single blind, placebo controlled Phase 2 dose escalation study assessing the safety and efficacy of ADXS-HPV for the treatment of cervical intraepithelial neoplasia (CIN) 2/3.
All received single blind placebo tablets for 4 weeks and were subsequently randomized to either placebo or 80 mg isoflavones for a further 12 weeks.
OTCBB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, has completed the first of 3 dose cohorts in the single blind, placebo controlled Phase 2 dose escalation study assessing the safety and efficacy of ADXS-HPV in the treatment of cervical intraepithelial neoplasia (CIN) 2/3.
Clinical single blind, randomized, and controlled trials of both drugs were conducted.
The multi-centre prospective, single blind, two-arm randomized OPTION study aims to demonstrate that patients implanted with dual chamber ICDs incorporating advanced features such as optimal dual chamber arrhythmia detection, a pacing mode that minimizes ventricular pacing and a slow ventricular tachycardia zone, have better outcomes in terms of inappropriate shokc delivery, patient mortality and hospitalizations than patients with single chamber devices.
CombinatoRx, Incorporated (NASDAQ: CRXX) today announced positive results of its single blind, phase 2, proof-of-concept clinical trial of CRx-170 in patients with asthma.
This is a 30-patient, placebo/baseline-controlled, single blind study using both polysomnography (PSG) and subjective sleep measurements to assess and better quantify sleep parameters.
The methodology of the study was a randomized, single blind, single center, crossover human pharmacokinetic study to compare the blood levels of testosterone as delivered from two transdermal systems and to evaluate skin irritation from those systems.
The study design included a 2- to 3-week single blind, placebo, run-in period, followed by a 1-week double-blind titration period, and a 2-week double-blind maintenance period.
The Phase II trial was a randomized, single blind, prospective, cross-over study conducted to evaluate the effects of Pumactant on early and late asthmatic responses in seven patients with allergic asthma, produced by exposure to allergens.